HER2 overexpression can lead to downstream signaling pathway overactivation, associate with increasing tumor cell proliferation and enhancing tumor invasiveness and angiogenesis, result in the pathogenesis and progression of solid tumors (Bartlett et al., 2001; Maennling et al., 2019; Henriques et al., 2021). The gene discussed is ERBB2; the disease is neoplasm.